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Abstract
Background: Congenital cardiovascular diseases are the most common form of birth defects in
humans. A substantial portion of these defects has been associated with inappropriate induction,
migration, differentiation and patterning of pluripotent cardiac neural crest stem cells. While TGF-
β-superfamily signaling has been strongly implicated in neural crest cell development, the detailed
molecular signaling mechanisms in vivo are still poorly understood.
Results: We deleted the TGF-β type I receptor Alk5 specifically in the mouse neural crest cell
lineage. Failure in signaling via ALK5 leads to severe cardiovascular and pharyngeal defects, including
inappropriate remodeling of pharyngeal arch arteries, abnormal aortic sac development, failure in
pharyngeal organ migration and persistent truncus arteriosus. While ALK5 is not required for
neural crest cell migration, our results demonstrate that it plays an important role in the survival
of post-migratory cardiac neural crest cells.
Conclusion: Our results demonstrate that ALK5-mediated signaling in neural crest cells plays an
essential cell-autonomous role in the pharyngeal and cardiac outflow tract development.
Background
A considerable percentage of cardiac birth defects is
caused by a failure in normal migration, differentiation or
patterning of the cardiac neural crest (CNC). This subset
of pluripotent neural crest stem cells forms in the dorsal
aspect of the neural tube at the level of the mid-otic pla-
code to the third somite [1]. Subsequently cardiac neural
crest cells (CNCCs) delaminate, undergo a phenotypic
transformation from an epithelial to mesenchymal cell
type, and migrate latero-ventrally into the 3rd, 4th and 6th
pharyngeal arch arteries (PAAs), where they contribute to
the formation of the smooth muscle cell layer of endothe-
lial structures derived from the aortic arch arteries [1-3]. A
subset of CNCCs continues to migrate deeper into the aor-
tic sac to form the aortico-pulmonary septum; a vital
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structure, which separates the pulmonary trunk from the
aorta [4].
An indispensable role of CNCCs in the development of
the cardiac outflow tract was originally demonstrated by
pioneering studies of Kirby and coworkers [1], who
showed that ablation of the CNC in the chick led to severe
outflow tract (OFT) defects including persistent truncus
arteriosus (PTA), mispatterning of the great vessels and
outflow tract mal-alignments [5]. Early migratory CNCCs
have been shown to retain a considerable degree of plas-
ticity and their fate is largely controlled by instructional
signals from local environments into which NCCs migrate
[6]. Several recent studies have indicated that members of
the TGF-β superfamily, i.e., TGF-βs and BMPs are likely
candidates to provide some of these signals. Mice defi-
cient in TGF-β2 display fourth aortic arch artery defects
[7], while neural crest cell specific abrogation of TGF-β
type II receptor (Tgfbr2) results in interruption of the aor-
tic arch and PTA [8,9]. BMPs 6 and -7 are required for
proper formation of the outflow tract cushions [10], while
BMP type II receptor is needed for proper development of
the conotruncal ridges [11]. Moreover, neural crest-spe-
cific deletion of the BMP type I receptors Alk2 and Alk3
has been shown to lead to defective aortico-pulmonary
septation, among other cardiac defects [12,13].
TGF-β subfamily ligands signal via a receptor complex
composed of two type II receptors and two type I receptors
[14,15]. Ligand binding leads to phosphorylation and
activation of type I receptors, which, in turn, phosphor-
ylate and activate a specific set of downstream signaling
molecules called Smads. In general terms, TGF-βs bind to
the TGF-β type II receptor (TGFβRII) and TGF-β type I
receptor (ALK5) activating TGF-β Smads (2 and 3), while
BMPs bind to the BMP type II receptor and type I receptors
ALK2, -3, or 6, activating BMP Smads (1, 5 and 8). How-
ever, it is likely that these signaling interactions are more
complex in vivo, possibly allowing formation of heterote-
trameric complexes composed of different type II and type
I receptors [16]. In addition, recent studies have identified
novel TGF-β-related ligands, which can bind to entire dif-
ferent combinations of receptors. For instance, growth
and differentiation factors (GDFs) 8 and 9 can bind to
Activin type II receptor and ALK5 to activate TGF-β Smads
[17,18]. Therefore, we hypothesized that deletion of Alk5
in a specific cell lineage should reveal phenotypes which
cannot be seen in comparable mutants lacking Tgfbr2.
Indeed, we recently showed that neural crest cell specific
Alk5 mutants display a unique spectrum of craniofacial
developmental defects, e.g., cleft snout and severe man-
dibular hypoplasia [19]; these phenotypes were not seen
in corresponding Tgfbr2  mutants [20]. To determine,
whether ALK5 would also mediate unique non-redundant
signaling events in cardiac neural crest cells, we focused
on cardiac and pharyngeal phenotypes of mouse embryos
lacking Alk5 specifically in neural crest cells. We discov-
ered that in Alk5/Wnt1-Cre mutants, pharyngeal organs
(thymus and parathyroid) fail to migrate appropriately.
Moreover, the mutant embryos display severe aortic sac
and pharyngeal arch artery defects, and failed aortico-pul-
monary septation leading to PTA. Our data further suggest
that at least some of these abnormal detected phenotypes
result from a dramatic increase in apoptosis of postmigra-
tory cardiac neural crest cells. These phenotypes differ
remarkably from those seen in corresponding Tgfbr2
mutants, suggesting that ALK5 mediates a wider spectrum
of signaling events than its classical binding partner TGF-
βRII in cardiac neural crest cells during cardiac and pha-
ryngeal development.
Results
Persistent truncus arteriosus and abnormal large vessels in 
mice lacking Alk5 in cardiac NCCs
To inactivate Alk5 in cardiac NCCs, mice homozygous for
the floxed Alk5 allele (Alk5Flox/Flox) [21] were crossed with
transgenic Wnt1-Cre mice [22], which were also hetero-
zygous for the Alk5 knockout allele (Alk5KO) allele. The
resulting mice heterozygous for the Alk5Flox and Alk5KO
alleles, which also carried the Wnt1-Cre transgene, had the
Alk5 gene specifically inactivated in NCCs (herein termed
Alk5/Wnt1-Cre), while the littermates with remaining
allelic combinations were phenotypically normal and
served as controls (Alk5Flox/+, Alk5KO/+; Wnt1-Cre). When
embryos were harvested during the last day of gestation,
an expected number (25%) of Alk5/Wnt1-Cre  mutants
were recovered. However, all mutant offspring died either
during the birth or during the first post-natal hours.
To determine, if ALK5-mediated TGF-β-signaling had a
role in development of the OFT and large vessels of the
aortic arch, we performed casting dye experiments on E17
embryos (Fig. 1A–D). In wild-type embryos (Fig. 1A), the
aorta was clearly separated from the pulmonary trunk,
and the right brachiocephalic, left carotid and left subcla-
vian arteries branched directly off the aortic arch. In con-
trast,  Alk5/Wnt1Cre  mutant embryos consistently
displayed a single prominent arterial trunk (Fig. 1C–D),
while corresponding Tgfbr2 mutant embryos (Fig. 1B) dis-
played interrupted aortic arch, as reported earlier [8].
Approximately 40% of the Alk5 mutants had a right-sided
outflow tract, with the retroesophageal arch connecting to
the descending aorta and to the left subclavian artery. The
carotid arteries originated either from a common bud
located in the ventral side of the ascending arch, or from
separate adjacent sites, as verified by serial sectioning (Fig.
1M–P). The remaining mutants displayed a left-sided aor-
tic arch, where the right carotid arteries originated from
the right lateral aspect of the ascending trunk, while the
left carotid arteries budded from the ventral or right ven-BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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tral aspects of the trunk (Fig. 1I–L). Both right and left
subclavian arteries consistently originated from the
descending part of the aortic arch. Similarly, in all
mutants both left and right pulmonary arteries always
branched out from the common arterial trunk. To con-
clude, Alk5/Wnt1-Cre mutants consistently displayed PTA,
which differed significantly from the characteristic inter-
rupted aortic arch phenotype seen in Tgfbr2/Wnt1-Cre
mutants [8,9].
Abnormal patterning of the pharyngeal arch arteries and 
aortic sac in Alk5/Wnt1Cre mutants
During cardiovascular development, the PAAs undergo a
complex set of sequential asymmetric remodeling steps
resulting in the left-sided aortic arch. To determine,
whether ALK5-mediated signaling was involved in remod-
eling of PAAs, we performed intracardiac India ink injec-
tions at different developmental stages. While at E10,
Alk5/Wnt1-Cre mutants did not show obvious differences
in the PAAs, abnormal remodeling became obvious in
mutants a day later at E11 (Fig. 2). The controls displayed
the well-formed 3rd, 4th  and 6th  PAAs. Moreover, the
carotid duct (the dorsal aorta between the 3rd and 4th
PAAs) was already regressing as demonstrated by the
reduced size (Fig. 2A). In Alk5/Wnt1-Cre mutants, the 3rd
and 4th pairs of PAAs were bilaterally hypoplastic, whereas
the 6th pair of PAAs was notably hyperplastic (Fig. 2B).
Furthermore, the carotid duct was remarkably large, when
compared to controls. While the controls displayed an
interruption of the carotid duct at E12 and E13 as
expected (Fig. 2C), the mutants demonstrated an unchar-
acteristic break of the dorsal aorta between the 4th and 6th
pairs of PAAs (Fig. 2D).
Around E11.5, the aortic sac normally forms a distinctive
T-shaped structure, as seen in frontal sections of the con-
trol sample in Fig. 3(A,C). Subsequently, the right horn of
this structure transforms into the prospective brachio-
cephalic artery, while the left horn together with the left
4th PAA gives rise to the definitive aortic arch [23]. In Alk5/
Wnt1-Cre mutants, the T-shaped aortic sac failed to form
(Fig. 3B,D). Instead, the truncus bifurcated to a left and
right arm, which further branched to the PAAs, particu-
larly to the predominant pair of 6th PAAs (Fig. 3B,D). The
observed phenotype is consistent with the absence or
severe hypoplasia of structures derived from the aortic sac
in late stage embryos (E17), e.g., the missing brachio-
cephalic artery and severe shortening of the ascending
truncus as shown in the Figure 1.
Cardiac NCCs deficient in Alk5 can populate the outflow 
tract
Next we used the R26R lineage-tracing assay to determine
whether CNCCs could appropriately populate the out-
flow tract region. Briefly, Alk5Flox/Flox mice were crossed
with the ROSA26 Cre reporter mice, and subsequently
Alk5Flox/Flox;R26R(+/+) females were crossed with Alk5KO/
WT;Wnt1-Cre males. The resulting embryos had the NC-
lineage permanently labeled with β-galactosidase expres-
sion, and displayed identical phenotypes to those
obtained without the R26R reporter. Staining of embryos
for β-galactosidase at E8-E11 did not reveal detectable dif-
ferences in NCC migration between mutants and controls
(data not shown). Similarly, serial transverse sectioning of
whole mount embryos (E10-E12) and subsequent analy-
sis of positively stained cells in the OFT region demon-
strated that CNCCs deficient in Alk5  were capable of
populating the PAAs, aortic sac and conotruncal ridges at
a level comparable to that of controls (Fig 4). To conclude,
the observed phenotypes in Alk5/Wnt1-Cre mutants were
certainly not due to defective migration of CNCCs to the
pharyngeal and outflow tract regions.
Aortic sac and aortico-pulmonary septal defects in Alk5/
Wnt1Cre mutant embryos
Septation of the outflow tract lumen begins in a cranial-
to-caudal direction, starting distally in the aortic sac and
proceeding toward the heart [24]. Initially, the condensed
mesenchyme derived from the NC forms in the base of the
aortic sac between the origins of 4th and 6th PAAs. Subse-
quently, two prongs of the developing aortico-pulmonary
(AP) septum extend into the truncal cushions and the aor-
tico-pulmonary septation complex crosses the aortic sac
cranially. In ink-injected control embryos at E11.5, a char-
acteristic conotruncal transition separating the truncus
and conus could be seen as a twisted configuration, result-
ing from a change in orientation of the truncal and conal
cushions (Fig. 5). In contrast, in Alk5/Wnt1-Cre mutants
the outflow tract appeared unusually straight, failing to
demonstrate the distinct conotruncal transition (Fig.
5B,D). This assay also clearly showed a dramatic reduc-
tion in the size of the aortic sac. Histological analysis of
control samples displayed the characteristic rotation of
the aortic sac and truncal OFT at the level where the AP
septation takes place and verified the presence of the dis-
tinctive condensed AP-septal mesenchyme, which gradu-
ally divided the OFT to the aorta and the pulmonary trunk
(asterisks in Fig. 6A). R26R lineage tracing showed that
this tissue is derived from the NC, while immunostaining
for  α-SMA showed differentiation into smooth muscle
(Fig 6B). In Alk5/Wnt1-Cre mutants the characteristic rota-
tion of the aortic sac and truncal OFT fails to take place
(Fig. 6G–L), and a properly formed AP-septum was not
detectable (Fig. 6G,H). R26R lineage tracing demon-
strated that the defects were not due to failure of NCCs to
reach the OFT region. NC-derived cells around the
abnomally bifurcated aortic sac, the abnormally large
sixth PAAs and the truncus demonstrated strong αSMA
staining (Fig. 6H,J,L). Recently, we showed that the NC-
specific mutants of the related type I receptor, Alk2, dis-BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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Abrogation of Alk5 in neural crest cells leads to persistent truncus arteriosus type A2 Figure 1
Abrogation of Alk5 in neural crest cells leads to persistent truncus arteriosus type A2. A-D, Casting-dye analysis of 
OFT morphogenesis at E17.0. Control (A), Tgfbr2/Wnt1-Cre mutant [8] (B) demonstrating the PTA type A4 (= truncus arterio-
sus with interrupted aortic arch [30]) and Alk5/Wnt1-Cre mutants demonstrating the right-sided (C) and left-sided (D) arches of 
the truncus. E-P, Histological cross-sections on four different levels (rostral to caudal) at E17.0. In a control (E-H), the ascend-
ing aorta (Ao) and pulmonary trunk (PT) are separated by the conotruncal septum. In Alk5/Wnt1-Cre mutants (I-P) the 
conotruncal septum fails to form, and either left-sided (I-L) or right-sided (M-P) aortic arch can be seen. Aberrant branching of 
carotid arteries from the truncus has been illustrated by black arrows (J and M). Ao, aorta; PT, pulmonary trunk; RSA, right 
subclavian artery; RCA, right carotid artery; LCA; left carotid artery; LSA, left subclavian artery; IAA, interrupted aortic arch; 
PTA, persistent truncus arteriosus.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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play PTA as well [12]. In Alk2/Wnt1-Cre mutants, the rota-
tion of the aortic sac and truncal OFT failed to occur (Fig.
6M–R) as seen in Alk5/Wnt1-Cre mutants. However, in
Alk2 mutants the 6th pair of the PAAs was grossly hypo-
plastic, and while the Alk2/Wnt1-Cre mutants displayed a
noticeable amount of septal tissue between the 4th and 6th
Abnormal patterning of the PAAs in Alk5/Wnt1-Cre mutants Figure 2
Abnormal patterning of the PAAs in Alk5/Wnt1-Cre mutants. Left lateral view after intracardiac ink injections to visu-
alize the developing PAAs at E11.0 (A,B), E12.0 (C, D) and E13.0 (E, F) in controls (A, C, E) and Alk5/Wnt1-Cre mutants (B, D, 
F). Arrow in A points to the regressing carotid duct. Asterisk in B depicts the corresponding structure in the mutant with no 
signs of regression. Asterisk in D illustrates the aberrant regression of the dorsal aorta between the 4th and 6th PAAs. PT, pul-
monary trunk; Ao, Aorta; TA, truncus arteriosus.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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PAAs (Fig. 6M,N), the condensed septal mesenchyme
lacking Alk2 failed to extend the prongs into the truncal
cushions and to form the AP septum. Concurrently, the
6th PAAs were losing their patency, which may have fur-
ther contributed to the failed AP septation (Fig. 6M,O,Q).
While CNCCs managed to migrate to the aortic sac and
the truncal cushion level (Fig. 6N,P,R), immunostaining
for αSMA appeared much weaker when compared to con-
trols and Alk5 mutants, implying that ALK2-mediated sig-
naling is involved in smooth muscle cell differentiation as
previously suggested [12]. To conclude, while both Alk2
and Alk5 mutants demonstrate a failure in both the rota-
tion of the aortic sac and the truncal OFT, and in the for-
mation of the AP septum, the pathogenetic mechanisms
behind these defects appear remarkably different.
Alk5/Wnt1-Cre mutants display increased apoptosis of 
post-migratory neural crest cells
As described above, Alk5/Wnt1-Cre mutants displayed an
inadequate amount of AP-septal tissue in the base of the
aortic sac between the origins of 4th and 6th PAAs. To ana-
lyze whether this phenotype resulted either from defective
CNCC proliferation or inappropriate apoptosis, we used
BrdU and TUNEL staining, respectively. While CNCC pro-
liferation was not affected in Alk5  mutants (data not
shown), we could detect a dramatic increase in the
number of TUNEL positive cells in tissues surrounding the
aortic sac including the site where the AP-septum forms
(Fig. 7A–C). Dual staining for lacZ and TUNEL positive
cells demonstrated that these cells were postmigratory
CNCCs; this phenotype was already clearly detectable at
E10.5. These results were confirmed by using immunos-
taining for cleaved caspase-3, another marker for apopto-
sis (Fig. 7I,J). In the chick, apoptotic neural crest-derived
cells have also been found at the sites, where the prongs of
the AP septum penetrate into the OFT cushion mesen-
chyme [25,26]. Thus, we compared apoptosis patterns
also on the more proximal level, but found no detectable
differences at E11.0 between Alk5/Wnt1-Cre mutants and
controls (Fig. 7D,E). Unlike in Alk5/Wnt1-Cre  mutant
embryos, increased apoptosis of NC-derived cells is not
responsible for the observed defects in the OFT septation
in corresponding Alk2 mutants (Fig. 7C,E).
To conclude, our results suggest that in Alk5/Wnt1-Cre
mutants a noticeable increase in apoptosis coincides with
the abnormal patterning of the PAAs and the aortic sac,
and with the failed AP-septation. These data support a
specific role for ALK5 signaling, either directly or indi-
rectly, in CNCC survival, since a similar apoptosis of NC-
derived cells is not seen in Tgfbr2/Wnt1-Cre mutants [8,9].
Pharyngeal organs fail to migrate in Alk5/Wnt1-Cre 
mutants
In addition to the cardiac OFT, development of pharyn-
geal organs, i.e., the parathyroid glands and the thymus
was also abnormal in Alk5/Wnt1-Cre mutants (see Figs. 1
and 8). Normally the thymus develops from the third
pharyngeal pouch endoderm and migrates caudally to its
final location in the superior mediastinum as seen in con-
trols at E14 (Fig. 8A,B). In contrast, the thymic primordia
of the Alk5 mutant littermates failed to descend caudally,
and were located bilaterally in the neck region, where they
were surrounded by neural crest-derived mesenchyme
(Fig. 8D,E). The fate determination assay demonstrated
that the thymic primordia were equally populated by
NCCs both in controls and Alk5 mutants (Fig. 8B,E). Like-
wise the parathyroid glands failed to migrate normally in
Alk5/Wnt1-Cre mutants. During normal development, the
parathyroids first migrate in association with the thymic
primordia, until they reach the thyroids in the neck region
Abnormal Aortic Sac in Alk5/Wnt1-Cre mutants Figure 3
Abnormal Aortic Sac in Alk5/Wnt1-Cre mutants. Alk5/
Wnt1-Cre mutants (B, D) fail to form the typical T-shaped 
structure of the aortic sac seen in controls at E11.5. (A, C). 
A-B, frontal image of ink-injected embryos; C-D, frontal sec-
tions (H&E staining). Arrows in A and B point to the level of 
section shown in C and D (red arrows in C and D point to 
the aortic sac of the control and mutant, respectively).BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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Normal cardiac NCC migration in Alk5/Wnt1-Cre mutants Figure 4
Normal cardiac NCC migration in Alk5/Wnt1-Cre mutants. The OFT of controls (A, C, E) and Alk5/Wnt1-Cre mutants 
(B, D, F) display similar staining patterns when analyzed using the R26R lineage tracing assay at E11.0. A-B, whole mount stain-
ing (left lateral image); C-F, transverse sections on the level of the 4th (C, D) and 6th (E, F) PAAs. Arrows (A-F) point to the 
most proximal location staining positive for the β-galactosidase activity.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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as seen in Fig 8C. In Alk5/Wnt1-Cre mutants, the parathy-
roids remained associated with the thymic primordia, and
despite this abnormal rostral location, expression of par-
athyroid hormone was indistinguishable between Alk5
mutants and controls at E14 (Fig. 8C,F). To conclude, the
observed pharyngeal organ phenotypes were also in strik-
ing contrast to those seen in Tgfbr2/Wnt1-Cre  mutants
[8,9].
Discussion
During the last few years the Wnt1-Cre transgenic driver
line has proven to be a powerful tool for tissue-specific
gene deletion in NCCs [12,13,27,28]. Using this
approach, several studies have independently shown that
the NC-specific deletion of the Tgfbr2 gene leads to a dis-
tinct set of calvarial, facial and cardiac defects [8,9,20,29].
Interestingly, these defects appear quite different both in
the craniofacial and pharyngeal regions, including the
heart, when compared to the corresponding mutants of
Alk5, which encodes the TGF-β type I receptor, a prototyp-
ical binding partner of TGF-βRII [19] and the present
study). While Tgfbr2/Wnt1-Cre mutants as well as mice
deficient in Tgf-β2 display the PTA type A4 (truncus arte-
riosus with interrupted aortic arch [30]), Alk5/Wnt1-Cre
mutants reported here demonstrate earlier patterning
defects of the PAAs, which is particularly obvious in the
3rd  pair of the PAAs. Moreover, the Alk5/Wnt1-Cre
mutants display an abnormal patterning of the aortic sac
and defective AP septation leading to PTA, reminiscent of
type A2 (= truncus artriosus with no main pulmonary
artery segment present [30]). However, our results also
demonstrate that significant hypoplasia of the aortic sac
leads to a severe shortening of the ascending truncal arch,
which masks possible defects in derivatives of the 4th
PAAs, i.e., interruption of the aortic arch. These observed
differences are likely due to substantial apoptosis of Alk5-
deficient post-migratory neural crest cells, which is clearly
The truncal OFT fails to rotate in Alk5/Wnt1-Cre mutants Figure 5
The truncal OFT fails to rotate in Alk5/Wnt1-Cre mutants. Left (A, C) and right (B, D) lateral images of ink-injected 
control (A-B) and mutant (C-D) embryos at E11.5 demonstrate the abnormally straight OFT in mutants lacking the typical 
conotruncal transition (black arrow in A vs. black arrowhead in C) seen in control. Red arrowhead (C) points to the abnor-
mally shaped aortic sac. Red "s", aortic sac; t, truncus; c, conus.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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detectable at E10.5, whereas similar intense cell death has
not been reported in Tgfbr2/Wnt1-Cre mutants[9].
Our present results suggest that while TGF-β signaling in
cardiac NCCs is predominantly mediated via the ALK5/
TGF-βRII receptor complex, ALK5 also mediates signaling
of other related ligands, which are either directly or indi-
rectly required for appropriate NCC survival. In fact, it has
been shown that, besides TGF-βRII, ALK5 can also form a
complex with the Activin type IIB receptor to activate
downstream Smads 2/3 [18,31]. Furthermore, a subset of
TGF-β-related growth and differentiation factors (GDFs),
e.g., GDF8, GDF9, GDF11 and GDF15 could induce these
events [17,18,32,33]. Although relevant Gdfs 8, 9 11 and
15 are not expressed in the developing heart, nor do the
mice deficient in these Gdfs display developmental cardiac
defects, we cannot exclude the possibility that circulating
GDFs, perhaps in concert with TGF-βs may contribute to
NCC survival during cardiac and pharyngeal morphogen-
esis.
We specifically studied apoptosis at the level of the aortic
sac, where the AP-septum forms between the origins of 4th
and 6th PAAs. Already at E10.5, we could see intense apop-
tosis among the postmigratory NCCs in the mesenchyme
surrounding the aortic sac at the site where the prospective
AP septum forms, i.e., this cell death precedes the AP sep-
tal defect seen in mutants. Although some NC-derived
cells appeared to be differentiating to smooth muscle cells
in the OFT (Fig. 6), we could never detect the AP septum
forming in Alk5/Wnt1-Cre mutants between E10.5 and
E11.5. These findings suggest that the pool of cells form-
ing the AP septum is severely affected by the cell death.
Moreover, it is likely that these cells forming the AP-sep-
tum die the before majority of them can differentiate to
smooth muscle cells.
Signaling via ALK5 and ALK2 controls different aspects of aortico-pulmonary septation Figure 6
Signaling via ALK5 and ALK2 controls different aspects of aortico-pulmonary septation. Frontal sections from dis-
tal (top row) to proximal (bottom row) of the control (A-F), Alk5/Wnt1-Cre mutant (G-L) and Alk2/Wnt1-Cre mutant (M-R) 
samples (E11.5). A, C, E, G, I, K, M, O, Q, H&E staining; B, D, F, H, J, L, N, P, R, double staining for αSMA (brown) and β-galac-
tosidase (green; R26R reporter assay). 6, the 6th PAA; AS, aortic sac; TA, truncus arteriosus; Ao, Aorta; PT, pulmonary trunk; 
Asterisks in A, B, M and N depict the AP septal mesenchyme.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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Aberrant apoptosis of NCCs in Alk5/Wnt1-Cre mutants Figure 7
Aberrant apoptosis of NCCs in Alk5/Wnt1-Cre mutants. TUNEL (A-H) and Cleaved Caspase-3 (I, J) staining at E11.0 
demonstrates a notable increase in apoptosis in Alk5/Wnt1-Cre mutants (B, H, J) on the aortic sac level when compared to con-
trols (A, G, I) or Alk2/Wnt1-Cre mutants (C) (frontal sections), while sections on the OFT level do not demonstrate differences 
between controls (D) and Alk5 (E) or Alk2 (F) mutants. G,H, TUNEL staining of lacZ-stained embryos demonstrates that apop-
totic cells are of neural crest origin. G, control; H, mutant. AS, aortic sac, arrows point to clusters of apoptotic cells surround-
ing the aortic sac.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
Page 11 of 14
(page number not for citation purposes)
Pharyngeal organs fail to migrate in Alk5/Wnt1-Cre mutants Figure 8
Pharyngeal organs fail to migrate in Alk5/Wnt1-Cre mutants. At E14.0, the thymus was not detectable in the superior 
mediastinum (asterisks) in Alk5 mutants (D), when compared to controls (A). Serial sectioning revealed that the thymic pri-
mordia had failed to descend and were seen bilaterally in the upper pharyngeal region (E, F) surrounded by neural crest derived 
mesenchyme (blue staining cells in E). In controls, the parathyroid glands were properly associated with the thyroid glands 
(arrows in C), while in Alk5 mutants the parathyroid glands were associated with the thymic primordia (arrows in F). However, 
both controls and mutants expressed parathyroid hormone (PTH) at comparable levels (blue staining in C and F). A and D, 
hematoxyllin and eosin staining; B and E, R26 R lineage tracing assay – counterstaining with eosin; C and F, section in situ 
hybridization for PTH – counterstaining with eosin. T, thymus; Th, thyroid; asterisks in D depict the absence of the thymic pri-
mordia; asterisks in E and F depict the tongue.BMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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Several in vitro studies have suggested an indispensable
role for TGF-β-signaling in differentiation of NCCs into
smooth muscle cells. Moreover, a recent in vivo study sug-
gested that mice lacking Tgfbr2 in CNCCs display defec-
tive NCC differentiation into αSMA-positive cells in the
AP septum [9], although this result was later disputed by
another study [8]. Our immunohistochemical staining of
αSMA in the OFT unequivocally demonstrated that sign-
aling via ALK5 is not required for smooth muscle differen-
tiation  in vivo. Moreover, it has been suggested that
deletion of Tgfbr2 in NCCs leads to other phenotypic fea-
tures reminiscent of those seen in the velocardiofacial/
DiGeorge syndrome (VCF/DGS) [9] caused by a deletion
of the so called DiGeorge critical region (DGCR) on chro-
mosome 22q11 [34,35]. Our present results suggest that
although many of the observed phenotypes seen in Alk5/
Wnt1-Cre  mutants superficially resemble those seen in
VCF/DGS, a detailed examination shows that the NC-spe-
cific abrogation of Alk5 does not lead to VCF/DGS-like
phenotypes. Firstly, while the pharyngeal organ migration
fails in Alk5/Wnt1-Cre  mutants, perhaps as a result of
increased mesenchymal cell death in the pharyngeal
region, both the thymus, thyroid and parathyroid seem to
develop relatively normally on the histological level in
these mutants. Secondly, the NCC death seen in Alk5
mutants affects a predominantly postmigratory popula-
tion of NCCs, while genes located in the DGCR, i.e., Tbx1
and CrkL, control NCC survival earlier at E8.5-E10 by reg-
ulating proliferation of the secondary heart field (SHF),
and endoderm expansion, which in turn provides survival
signal for NCCs allowing them to populate the pharyn-
geal region [36-39].
NCC ablation in the chick has been shown to lead to PTA
and to a failure of addition of myocardium from the sec-
ondary heart field [40]. It was suggested that the defective
migration of cells from the secondary heart field to the
OFT in turn resulted in shortening and inappropriate rota-
tion of the OFT, leading to mal-alignment of the arterial
pole with the ventricles [41]. While the detected OFT phe-
notype in Alk5/Wnt1-Cre mutants shared many similari-
ties with that seen in the chick NC ablation models, e.g.,
PTA and the hypoplastic aortic sac, our current results sug-
gest that the secondary heart field is not severely affected
in Alk5 mutants (data not shown). Since we could not
detect appropriate rotation of the OFT in neural crest-spe-
cific mutants of Alk5 or Alk2, it appears that cells derived
from the NC, as well as those from the SHF, are mutually
required for proper OFT rotation in mice. However, it
appears that these two TGF-β/BMP type I receptors con-
tribute to OFT rotation through different mechanisms. In
Alk5 mutants there is very little, if any, detectable septal
mesenchyme present, and thus it could be argued that in
these mutants OFT rotation fails due to a lack of penetra-
tion of septal prongs into the cushion mesenchyme. In
contrast, in Alk2/Wnt1-Cre mutants a sizeable septal mes-
enchyme could be seen, still without any obvious looping
of the aortic sac and truncal OFT, suggesting that the mere
presence of the septal mesenchyme, without correct
smooth muscle cell differentiation, is not sufficient for
OFT rotation.
Conclusion
In this study, we have deleted the TGF-β type I receptor
(Alk5) gene specifically in the mouse neural crest (NC)
cell lineage. Our data suggest that ALK5 is required cell
autonomously in the NC to mediate non-redundant sign-
aling events that are essential for appropriate patterning of
the pharyngeal organs and cardiac OFT. The cardiac and
pharyngeal defects observed in the NC-specific Alk5
mutants differ significantly from those seen in corre-
sponding mutants lacking the TGF-β type II receptor, sug-
gesting that signaling mediated by ALK5 is not limited to




Alk5 (and Alk2) mutant and control embryos were gener-
ated by mating Alk5ko/+(Alk2ko/+)/Wnt1-Cre male mice
with females homozygous for the Alk5flox (Alk2flox) allele
and the R26R reporter[12,19]. Genotyping was performed
by PCR as described earlier [21,42]. Wnt1-Cre mice were
kindly provided by A. McMahon (Harvard University)
and R26R reporter mice were obtained from the Jackson
laboratories. All studies were carried out at the Animal
Care Facility of the Saban Research Institute of Childrens
Hospital Los Angeles in accordance with institutional
guidelines.
Timed mataings
Mice were mated during the dark period of the controlled
light cycle; presence of vaginal plugs was designated as
day 0 hour 0. Females were euthanized by CO2, and
embryos were collected in Hanks' balanced salt solution
on ice.
Histological analyses
Embryos (E17) were fixed with 4% paraformaldehyhe for
14 hours, dehydrated and embedded in paraffin wax. Sec-
tions (7–8 um) were stained with Hematoxylin and Eosin
(n≥3 for each genotype). For lineage tracing analyses,
embryos were stained for β-galactosidase activity as
described [43]. Briefly, the specimens (E11.0 – E11.5)
were fixed in 4% paraformaldehyde for 30 minutes at
room temperature, washed 3 times for 10 minutes in the
detergent wash and developed for 2–12 hours in X-gal
solution (n≥3 for each genotype). For immunohisto-
chemistry, fixed sections from tissues harvested at E10.5 –
E11.5 were stained with monoclonal α-smooth muscleBMC Developmental Biology 2006, 6:51 http://www.biomedcentral.com/1471-213X/6/51
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actin (DAKO), cleaved caspase-3 (Cell Signaling) or pho-
phohistone-H3 (Cell Signaling) antibodies. TUNEL assays
were performed using the DeadEnd fluorometric TUNEL
system (Promega). In each assay 3 or more embryos were
analyzed for each genotype.
Ink and casting dye injections
Embryos (E10.0 – E13.0) were dissected and placed in ice
cold PBS (n≥3 per genotype in each time point). Using a
pulled glass pipette, India ink or Yellow casting dye (Con-
necticut Valley Biological Supply) was injected into the
ventricles until ink/dye penetrated small vessels. Embryos
were postfixed in 10% buffered formalin for 12 hours,
dehydrated and cleared in benzylbenzoate: benzyl alco-
hol (2:1v/v).
Expression analyses
To visualize parathyroid hormone expression we used in
situ hybridization and an antisense probe corresponding
to nucleotides 97–534 (kindly provided by Nancy
Manley) as described [44].
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